CLINICAL RESEARCH: ACUTE CORONARY SYNDROMES
Impact of Clopidogrel in Patients With Acute Coronary Syndromes Requiring Coronary Artery Bypass SurgeryA Multicenter Analysis
Jeffrey S. Berger, MD, MS*,
Carla B. Frye, PharmD ,
Qing Harshaw, MD, PhD ,
Fred H. Edwards, MD ,
Steven R. Steinhubl, MD and
Richard C. Becker, MD*,*
* Division of Cardiology, Duke University School of Medicine, Duke Clinical Research Institute; Durham, North Carolina
EPI-Q, Inc., Oak Brook, Illinois
Department of Cardiothoracic Surgery, University of Florida, Jacksonville, Florida
Department of Cardiovascular Medicine, University of Kentucky, Lexington, Kentucky
Manuscript received April 3, 2008;
revised manuscript received June 27, 2008,
accepted August 11, 2008.
* Reprint requests and correspondence: Dr. Richard C. Becker, Duke Clinical Research Institute, 2400 Pratt Street, Durham, North Carolina 27705 (Email: richard.becker{at}duke.edu).
Objectives: The purpose of our multicenter study was to examine the impact of pre-operative administration of clopidogrel on reoperation rates, incidence of life-threatening bleeding, inpatient length of stay, and other bleeding-related outcomes in acute coronary syndrome (ACS) patients requiring cardiopulmonary bypass (coronary artery bypass graft surgery [CABG]) in a broad cross section of U.S. hospitals.
Background: There is relative uncertainty about the relationship between clopidogrel and CABG-associated outcomes in the setting of ACS.
Methods: A retrospective cohort analysis was performed of randomly selected ACS patients requiring CABG in 14 hospitals across the U.S. Patients exposed to clopidogrel were compared with those not exposed to clopidogrel within 5 days prior to surgery.
Results: Of the 596 patients enrolled in the study, 298 had been exposed to clopidogrel within 5 days (Group A). Patients in Group A were more than 3-fold more likely to require reoperation for assessment of bleeding than patients not exposed to clopidogrel (6.4% vs. 1.7% Group B, p = 0.004). Major bleeding occurred in 35% of Group A patients versus 26% of Group B patients (p = 0.049). Length of stay was greater in Group A compared with Group B (9.7 ± 6.0 days vs. 8.6 ± 4.7 days, unadjusted p = 0.016). After logistic regression analysis, clopidogrel exposure within 5 days of CABG was the strongest predictor of reoperation (odds ratio [OR]: 4.60, 95% confidence interval [CI]: 1.45 to 14.55) and major bleeding (OR: 1.824, 95% CI: 1.106 to 3.008).
Conclusions: After ACS, patients who undergo CABG within 5 days of receiving clopidogrel are at increased risk for reoperation, major bleeding, and increased length of stay. These risks must be balanced by the clinical benefits of clopidogrel use demonstrated in randomized clinical trials.
Key Words: clopidogrel coronary artery bypass graft surgery acute coronary syndrome
|
Abbreviations and Acronyms
| | ACC/AHA = American College of Cardiology/American Heart Association | | ACS = acute coronary syndrome | | CABG = coronary artery bypass graft surgery | | CI = confidence interval | | LOS = length of stay | | OR = odds ratio |
|
Related Article
-
Inside This Issue of JACC
J. Am. Coll. Cardiol. 2008 52: A33.
[Full Text]
[PDF]
This article has been cited by other articles:

|
 |

|
 |
 
U. Alstrom, L.- A. Levin, E. Stahle, R. Svedjeholm, and O. Friberg
Cost analysis of re-exploration for bleeding after coronary artery bypass graft surgery
Br. J. Anaesth.,
February 1, 2012;
108(2):
216 - 222.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Writing Committee Members, L. D. Hillis, P. K. Smith, J. L. Anderson, J. A. Bittl, C. R. Bridges, J. G. Byrne, J. E. Cigarroa, V. J. DiSesa, L. F. Hiratzka, et al.
2011 ACCF/AHA guideline for coronary artery bypass graft surgery: Executive summary A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.
J. Thorac. Cardiovasc. Surg.,
January 1, 2012;
143(1):
4 - 34.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. D. Hillis, P. K. Smith, J. L. Anderson, J. A. Bittl, C. R. Bridges, J. G. Byrne, J. E. Cigarroa, V. J. DiSesa, L. F. Hiratzka, A. M. Hutter Jr, et al.
Special Article: 2011 ACCF/AHA Guideline for Coronary Artery Bypass Graft Surgery: Executive Summary: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines
Anesth. Analg.,
January 1, 2012;
114(1):
11 - 45.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. D. Hillis, P. K. Smith, J. L. Anderson, J. A. Bittl, C. R. Bridges, J. G. Byrne, J. E. Cigarroa, V. J. DiSesa, L. F. Hiratzka, A. M. Hutter Jr, et al.
2011 ACCF/AHA Guideline for Coronary Artery Bypass Graft Surgery: Executive Summary: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines Developed in Collaboration With the American Association for Thoracic Surgery, Society of Cardiovascular Anesthesiologists, and Society of Thoracic Surgeons
J. Am. Coll. Cardiol.,
December 6, 2011;
58(24):
2584 - 2614.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. D. Hillis, P. K. Smith, J. L. Anderson, J. A. Bittl, C. R. Bridges, J. G. Byrne, J. E. Cigarroa, V. J. DiSesa, L. F. Hiratzka, A. M. Hutter Jr, et al.
2011 ACCF/AHA Guideline for Coronary Artery Bypass Graft Surgery: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines Developed in Collaboration With the American Association for Thoracic Surgery, Society of Cardiovascular Anesthesiologists, and Society of Thoracic Surgeons
J. Am. Coll. Cardiol.,
December 6, 2011;
58(24):
e123 - e210.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Writing Committee Members, L. D. Hillis, P. K. Smith, J. L. Anderson, J. A. Bittl, C. R. Bridges, J. G. Byrne, J. E. Cigarroa, V. J. DiSesa, L. F. Hiratzka, et al.
2011 ACCF/AHA Guideline for Coronary Artery Bypass Graft Surgery: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines
Circulation,
December 6, 2011;
124(23):
e652 - e735.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Writing Committee Members, L. D. Hillis, P. K. Smith, J. L. Anderson, J. A. Bittl, C. R. Bridges, J. G. Byrne, J. E. Cigarroa, V. J. DiSesa, L. F. Hiratzka, et al.
2011 ACCF/AHA Guideline for Coronary Artery Bypass Graft Surgery: Executive Summary: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines
Circulation,
December 6, 2011;
124(23):
2610 - 2642.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. S. Nijjer, G. Watson, T. Athanasiou, and I. S. Malik
Safety of clopidogrel being continued until the time of coronary artery bypass grafting in patients with acute coronary syndrome: a meta-analysis of 34 studies
Eur. Heart J.,
December 1, 2011;
32(23):
2970 - 2988.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Authors/Task Force Members, C. W. Hamm, J.-P. Bassand, S. Agewall, J. Bax, E. Boersma, H. Bueno, P. Caso, D. Dudek, S. Gielen, et al.
ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: The Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC)
Eur. Heart J.,
December 1, 2011;
32(23):
2999 - 3054.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Ranucci
Reply
Ann. Thorac. Surg.,
August 1, 2011;
92(2):
779 - 779.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Ranucci, S. Aronson, W. Dietrich, C. M. Dyke, A. Hofmann, K. Karkouti, M. Levi, G. J. Murphy, F. W. Sellke, L. Shore-Lesserson, et al.
Patient blood management during cardiac surgery: Do we have enough evidence for clinical practice?
J. Thorac. Cardiovasc. Surg.,
August 1, 2011;
142(2):
249.e1 - 249.e32.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. A. Ferraris, J. R. Brown, G. J. Despotis, J. W. Hammon, T. B. Reece, S. P. Saha, H. K. Song, E. R. Clough, L. J. Shore-Lesserson, L. T. Goodnough, et al.
2011 Update to The Society of Thoracic Surgeons and the Society of Cardiovascular Anesthesiologists Blood Conservation Clinical Practice Guidelines
Ann. Thorac. Surg.,
March 1, 2011;
91(3):
944 - 982.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. E. Hussaini, H. S. Thatte, B. A. Rhodes, P. R. Treanor, and V. Birjiniuk
Thromboresistant surfaces with low-dose anticoagulation alleviate clopidogrel-related complications in patients undergoing coronary artery bypass grafting
J. Thorac. Cardiovasc. Surg.,
March 1, 2011;
141(3):
782 - 788.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Hall and C. D. Mazer
Review Article: Antiplatelet Drugs: A Review of Their Pharmacology and Management in the Perioperative Period
Anesth. Analg.,
February 1, 2011;
112(2):
292 - 318.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. F. Slaughter
Invited Commentary
Ann. Thorac. Surg.,
January 1, 2011;
91(1):
129 - 130.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y.-L. Kwak, J.-C. Kim, Y.-S. Choi, K.-J. Yoo, Y. Song, and J.-K. Shim
Clopidogrel Responsiveness Regardless of the Discontinuation Date Predicts Increased Blood Loss and Transfusion Requirement After Off-Pump Coronary Artery Bypass Graft Surgery
J. Am. Coll. Cardiol.,
December 7, 2010;
56(24):
1994 - 2002.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Montalescot, J.-S. Hulot, and J.-P. Collet
Antiplatelet Therapy and Coronary Artery Bypass Graft Surgery: A Fallow Land
J. Am. Coll. Cardiol.,
December 7, 2010;
56(24):
2003 - 2005.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Ranucci, S. Castelvecchio, and A. Ballotta
Chapter 76 Perioperative management of the high-risk cardiac surgery patient
The ESC Textbook of Acute and Intensive Cardiac Care,
December 1, 2010;
1(1):
med-9780199584314-chapter - med-9780199584314-chapter.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Mahla, H. Metzler, U. S. Tantry, and P. A. Gurbel
Controversies in Oral Antiplatelet Therapy in Patients Undergoing Aortocoronary Bypass Surgery
Ann. Thorac. Surg.,
September 1, 2010;
90(3):
1040 - 1051.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. GUTIERREZ and S. V. RAO
Incidence, outcomes, and management of bleeding in non-ST-elevation acute coronary syndromes
Cleveland Clinic Journal of Medicine,
June 1, 2010;
77(6):
369 - 379.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Preisman, A. Kogan, K. Itzkovsky, G. Leikin, and E. Raanani
Modified thromboelastography evaluation of platelet dysfunction in patients undergoing coronary artery surgery,
Eur J Cardiothorac Surg,
June 1, 2010;
37(6):
1367 - 1374.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Hirose, C. Noguchi, H. Inaba, K. Tambara, T. Yamamoto, M. Yamasaki, K. Kikuchi, and A. Amano
The role of EuroSCORE in patients undergoing off-pump coronary artery bypass
Interact CardioVasc Thorac Surg,
May 1, 2010;
10(5):
771 - 776.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. V. Parikh, J. A. de Lemos, M. E. Jessen, E. S. Brilakis, E. M. Ohman, A. Y. Chen, T. Y. Wang, E. D. Peterson, M. T. Roe, E. M. Holper, et al.
Timing of In-Hospital Coronary Artery Bypass Graft Surgery for Non-ST-Segment Elevation Myocardial Infarction Patients: Results From the National Cardiovascular Data Registry ACTION Registry-GWTG (Acute Coronary Treatment and Intervention Outcomes Network Registry-Get With The Guidelines)
J. Am. Coll. Cardiol. Intv.,
April 1, 2010;
3(4):
419 - 427.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. L. Anderson and J. R. Doty
Bypass Surgery After Non-ST-Segment Elevation Myocardial Infarction: Better Early Than Late?
J. Am. Coll. Cardiol. Intv.,
April 1, 2010;
3(4):
428 - 430.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. M. Schill
Plasma sequestration: a good therapy to prevent the deleterious effect of clopidogrel when clopidogrel is used within one to four days of coronary bypass surgery
Perfusion,
March 1, 2010;
25(2):
91 - 95.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
S. F. Aranki and S. C. Body
Antiplatelet agents used for early intervention in acute coronary syndrome: Myocardial salvage versus bleeding complications.
J. Thorac. Cardiovasc. Surg.,
October 1, 2009;
138(4):
807 - 810.e7.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Hirose, H. Inaba, C. Noguchi, K. Tambara, T. Yamamoto, M. Yamasaki, K. Kikuchi, and A. Amano
EuroSCORE predicts postoperative mortality, certain morbidities, and recovery time
Interact CardioVasc Thorac Surg,
October 1, 2009;
9(4):
613 - 617.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. S. Berger, C. B. Frye, Q. Harshaw, F. H. Edwards, S. R. Steinhubl, and R. C. Becker
Reply
J. Am. Coll. Cardiol.,
June 30, 2009;
54(1):
90 - 91.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Ebrahimi, C. Dyke, R. Mehran, S. V. Manoukian, F. Feit, D. A. Cox, B. J. Gersh, E. M. Ohman, H. D. White, J. W. Moses, et al.
Outcomes Following Pre-Operative Clopidogrel Administration in Patients With Acute Coronary Syndromes Undergoing Coronary Artery Bypass Surgery: The ACUITY (Acute Catheterization and Urgent Intervention Triage strategY) Trial
J. Am. Coll. Cardiol.,
May 26, 2009;
53(21):
1965 - 1972.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. M. Barker and H. V. Anderson
Acute Coronary Syndromes: Don't Bypass the Clopidogrel
J. Am. Coll. Cardiol.,
May 26, 2009;
53(21):
1973 - 1974.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. R. Movahed
Regarding Comparison of Percutaneous Coronary Intervention With Bare-Metal and Drug-Eluting Stents for Cardiac Allograft Vasculopathy: Problems With Listing Patients Receiving Clopidogrel for Re-Transplantation
J. Am. Coll. Cardiol. Intv.,
May 1, 2009;
2(5):
474 - 474.
[Full Text]
[PDF]
|
 |
|
|